USPTO serial 79136407
QIAGEN GENEREAD
Reviewed by CopyMark Law Group
Reg. 4824206Status 404
- Filing date
- Status date
- Registration date
- Oct 6, 2015
- Examiner
- RAPPAPORT, SETH
- Law office
- GENERIC WEB UPDATE
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with QIAGEN GENEREAD?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Victoria Friedman
Victoria Friedman Dennemeyer & Associates, LLC2 North Riverside Plaza, Suite 1500Chicago, IL 60606UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, diagnostic preparations except for human or veterinary medical purposes, non-medical chemical reagents, enzymes and chemicals solutions in the nature of buffer solutions for scientific and/or medical research use for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; kits comprising chemicals for laboratory or research use for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids of biological or biochemical sample material, in particular comprising chemicals for reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing | SECTION 70 - CANCELLED | — |
| 005 | Diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic preparations for humans for medical purposes; preparations for medical and veterinary purposes, namely, diagnostic preparations, for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; chemical, biochemical and biotechnological preparations for medical and veterinary purposes, namely, diagnostic reagents, enzymes and diagnostic reagents in the nature of buffer solutions for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; kits containing preparations for medical and veterinary diagnostic purposes primarily consisting of diagnostic preparations for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing | SECTION 70 - CANCELLED | — |
| 009 | Computer software for use in scientific and medical research for assisting in analyzing and sequencing biomolecules, namely, nucleic acids | SECTION 70 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Qiagen GmbH
- Other trademarks owned by Qiagen GmbH
- Other trademarks owned by Qiagen GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Similar marks named QIAGEN GENEREAD
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 4, 2024 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Feb 4, 2024 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jul 6, 2022 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Jul 6, 2022 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Jul 5, 2022 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Sep 20, 2021 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Oct 6, 2020 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 18, 2018 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 18, 2016 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 29, 2016 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 29, 2016 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 6, 2016 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 6, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 21, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 21, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 17, 2015 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 1, 2015 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 1, 2015 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 1, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 16, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 16, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 16, 2015 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 16, 2015 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 16, 2015 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 16, 2015 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 20, 2015 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 4, 2015 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 4, 2015 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Dec 29, 2014 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 18, 2014 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Nov 18, 2014 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 18, 2014 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 18, 2014 | ALIE | ASSIGNED TO LIE | — |
| Aug 22, 2014 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 15, 2014 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| May 15, 2014 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| May 15, 2014 | CNSL | SUSPENSION LETTER WRITTEN | — |
| May 10, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 10, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 28, 2014 | ALIE | ASSIGNED TO LIE | — |
| Apr 9, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 23, 2013 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 1, 2013 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 30, 2013 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 30, 2013 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 29, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 25, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 15, 2013 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 10, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 3, 2013 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |